Seems like United States President Donald Trump is in the mood to impose taxes on everything coming to America from other ...

India lacks a dedicated early warning system for detecting and responding to emerging drug threats like NPS or synthetic ...

Thirty-eight drug samples, including 10 injections, manufactured by various pharmaceutical companies in the state, have ...

Earlier in February, the New Delhi bench of the National Company Law Tribunal (NCLT) approved the amalgamation of Shree Jee ...

As the April 2 deadline for Trump’s reciprocal tariffs approaches, Indian markets brace for potential disruptions. While ...

The move follows the approval from the National Company Law Tribunal (NCLT), New Delhi Bench. With this consolidation, the ...

US President Donald Trump said that he is open to negotiating deals with countries seeking to avoid US reciprocal tariffs after April 2.

Indian pharma companies may stand to gain market share due to the potential impact of US tariffs, according to a JPMorgan report.

NPPA notifies revised prices of certain products based on WPI increase: Gireesh Babu, New Delhi Saturday, March 29, 2025, 08:00 Hrs [IST] The National Pharmaceutical Pricing Autho ...

The Board of Directors, in a meeting held on 25 March 2025, declared an interim dividend of Rs 25 per equity share on a face ...

Eli Lilly has priced Mounjaro at approximately Rs 4,375 ($50) for a single 5 mg injection, while the 2.5 mg variant costs Rs ...

The Board of Investment highlighted Thailand’s strategic advantages as it seeks to position itself as a regional hub for high ...